NCR3 and neoplasm: NK cell activation occurs through an interaction between triggering receptors, such as NKp30, NKp44, NKp46 and natural killer group 2D (NKG2D), and tumor cell ligands, which is finely balanced between inhibitory receptors and coreceptors 55.